Valuation dashboard for Neonc Technologies Holdings, Inc. (NTHI) with P/E N/A, P/B -4.25, EV/EBITDA -2.95 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Analysis Summary
Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.
At the current price of $2.99, NTHI has negative trailing earnings (P/E not meaningful) and an ROE of 309.09%. Market capitalisation stands at $78M.
Balance sheet quality for NTHI: current ratio of 0.1. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | -4.25 |
| EV / EBITDA | -2.95 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-0.69 |
| vs Current Price | -122.9% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| NTHI | Neonc Technologies Holdings, Inc. | $78M | 309.1% | ||
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.3B | 29.68 | 6.45 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $2.99 |
| Market Cap | $78M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 309.09% |
| Return on Invested Capital | 229.42% |
| Return on Assets | -902.18% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Explore sector: Healthcare · Biotechnology
More sections of NTHI: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks